Abstract
We provide here step-by-step protocols for the quantification of drugs/endogenous metabolites on dried blood spots (DBS) cards. DBS is a micro-volume blood collection technique in which aliquots of whole blood are deposited on specially manufactured filter paper, dried at ambient temperature, extracted, and then analyzed. We have developed liquid chromatography tandem mass spectrometry (LC/MS/MS) based drug and metabolite profiling assays for assessing triglycerides synthesis (energy storage) and acylcarnitine profiling for evaluation of fatty acid oxidation after drug exposure. Briefly, blood samples are spotted on dried blood filter paper. A metal punch with a 3-mm or 6-mm diameter is used to accurately cut a certain size disc. For extraction, an appropriate volume of extraction solvent containing internal standards is applied to extract analyte(s) from the loaded blood disc. The supernatant is separated and transferred to a new set of 96- or 384-well plates for LC/MS/MS analysis. There are two types of DBS cards now commercially available including chemical impregnated and no chemical treated. Chemical impregnated DBS cards offer instant blood cells and bacteria lysis, viral deactivation and enzymatic inhibition, generally leading to improved drugs and metabolites stability during sample collection, storage and transport process. The major pitfall of chemical impregnated DBS cards is the increased matrix effect which may affect the assay precision and accuracy. Therefore, a preliminary evaluation is recommended prior to application to select a specific type of cards with the best recovery and minimal matrix effects. The change in blood endogenous metabolite levels in response to drug treatment, using these assays, can serve as biomarkers for studies on pharmacokinetic (PK) and pharmacodynamic (PD) correlations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bang I (1913) A method for microdetermination of blood components. Biochem Z 49:19–39
Bang I (1918) The microdetermination of glucose. II. Biochem Z 92:344–346
Bang I (1918) Microdetermination of blood lipoids. Biochem Z 91:235–256
Guthrie R, Suzi A (1963) A simple phenylalanine method for detecting phenyketonuria in large populations of newborn infants. Pediatrics 32:338–343
Xu Y, Woolf EJ, Agrawal NGB, Kothare P, Pucci V, Bateman KP (2013) Merck’s perspective on the implementation of dried blood spot technology in clinical drug development—why, when and how. Bioanalysis 5:341–350
Kapur S, Kapur S, Zava D (2008) Cardiometabolic risk factors assessed by a finger stick dried blood spot method. J Diabetes Sci Technol 2:236–241
Dainty TC, Richmond ES, Davies I, Blackwell MP (2012) Dried blood spot bioanalysis: an evaluation of techniques and opportunities for reduction and refinement in mouse and juvenile rat toxicokinetic studies. Int J Toxicol 31:4–13
Turpin PE, Burnett JE, Goodwin L, Foster A, Barfield M (2010) Application of the DBS methodology to a toxicokinetic study in rats and transferability of analysis between bioanalytical laboratories. Bioanalysis 2:1489–1499
Ghanta VK, Hiramoto NS, Soong SJ, Hiramoto RN (1991) Survey of thymic hormone effects on physical and immunological parameters in C57BL/6NNia mice of different ages. Ann N Y Acad Sci 621:239–255
Nahas K, Provost JP (2002) Blood sampling in the rat: current practices and limitations. Comp Clin Pathol 11:14–37
O’Mara M, Hudson-Curtis B, Olson K, Yueh Y, Dunn J, Spooner N (2011) The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples. Bioanalysis 3:2335–2347
Alfazil AA, Anderson RA (2008) Stability of benzodiazepines and cocaine in blood spots stored on filter paper. J Anal Toxicol 32:511–515
D’Arienzo CJ, Ji QC, Discenza L, Cornelius G, Hynes J, Cornelius L, Santella JB, Olah T (2010) DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors. Bioanalysis 2:1415–1422
Clavijo CF, Hoffman KL, Thomas JJ, Carvalho B, Chu LF, Drover DR, Hammer GB, Christians U, Galinkin JL (2011) A sensitive assay for the quantification of morphine and its active metabolites in human plasma and dried blood spots using high-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 400:715–728
Michopoulos F, Theodoridis G, Smith CJ, Wilson ID (2010) Metabolite profiles from dried biofluid spots for metabonomic studies using UPLC combined with oaToF-MS. J Proteome Res 9:3328–3334
Kong ST, Lin H, Ching J, Ho PC (2011) Evaluation of dried blood spots as sample matrix for gas chromatography/mass spectrometry based metabolomic profiling. Anal Chem 83:4314–4318
Wilson I, Mereside AP (2011) Global metabolic profiling (metabonomics/metabolomics) using dried blood spots: advantages and pitfalls. Bioanalysis 3:2255–2257
Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, Yang E, Farrell L, Fox CS, O’Donnell CJ, Carr SA, Vasan RS, Florez JC, Clish CB, Wang TJ, Gerszten RE (2011) Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes predction in humans. J Clin Invest 121:1402–1411
Fingerhut R, Roschinger W, Muntau AC, Dame T, Kreischer J, Arnecke R, Superti-Furga A, Troxler H, Liebl B, Olgemoller B, Roscher AA (2001) Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific. Clin Chem 47:1763–1768
Paglia G, D’Apolito O, Corso G (2008) Precursor ion scan profiles of acylcarnitines by atmospheric pressure thermal desorption chemical ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 22:3809–3815
Fingerhut R, Regina E, Roschinger W, Ro W, Arnecke R, Olgemöller B, Roscher AA (2009) Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency. Anal Chem 81:3571–3575
Acknowledgements
The views expressed here are solely those of the author and do not reflect the opinions of Janssen Research & Development, LLC.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Lang, W., Qi, J., Caldwell, G.W. (2014). Drug, Lipid, and Acylcarnitine Profiling Using Dried Blood Spot (DBS) Technology in Drug Discovery. In: Caldwell, G., Yan, Z. (eds) Optimization in Drug Discovery. Methods in Pharmacology and Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-742-6_27
Download citation
DOI: https://doi.org/10.1007/978-1-62703-742-6_27
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-741-9
Online ISBN: 978-1-62703-742-6
eBook Packages: Springer Protocols